Navigation Links
FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients
Date:10/24/2013

RARITAN, N.J., Oct. 24, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted unanimously (19 to 0) to recommend approval of the investigational protease inhibitor simeprevir (TMC435) administered once daily as a 150 mg capsule with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease, including cirrhosis. The Advisory Committee recommended the approval of simeprevir based on analyses of data from clinical trials in patients who are treatment-naive or who have failed previous interferon-based therapy.

"We are pleased with the positive recommendation from the Advisory Committee for simeprevir and appreciate the rigorous review of our data," said Katia Boven, M.D., Medical Department Head, Infectious Diseases and Vaccines, Janssen. "It is our hope that the FDA will consider this recommendation and, upon completion of its review process, make simeprevir available to patients with genotype 1 chronic hepatitis C."

The FDA granted a Priority Review designation in May to the New Drug Application (NDA) filed by Janssen for simeprevir. Recommendations and findings from the Advisory Committee are based in part on efficacy and safety data from an extensive clinical development program for simeprevir and will be considered by the FDA in its review of the NDA for simeprevir, but the FDA is not required to follow them.  

The regulatory submission for simeprevir is supported in part by data from three pivotal Phase 3 studies – QUEST-1 and QUEST-2 in treatment-naive patients and PROMISE in patients who have relapsed after prior interferon-based treatment – as well as data from the Phase 2b ASPIRE study in prior non-responder patients. Janssen R&D Ireland presented data
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vaccinogen Names Dr. Benjamin Carson and Dr. Jan B. Vermorken to Medical Advisory Board
2. BSMA Expands Advisory Board to Advance BIOTECH SUPPLY CHAIN
3. Egenix, Inc. Appoints Matthew Fury, M.D., Ph.D. to its Scientific Advisory Committee
4. Boyd "Rainmaker" Melson, Professional Athlete and Advocate for Spinal Cord Injury Treatment, Signs on as Advisory Board Member of Store-A-Tooth™ Dental Stem Cell Banking
5. PennWells Strategies in Biophotonics Event Adds Two New Advisory Board Members
6. Dr. David R. Bassett Joins ActiGraph Scientific Advisory Board
7. Creabilis Appoints Professor Gil Yosipovitch and Professor Praveen Anand to its Scientific Advisory Board
8. Generex Confirms Conference Call with Members of the Antigen Express Scientific Advisory Board
9. Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board
10. Dr. Victor KR Matsudo Joins ActiGraph Scientific Advisory Board
11. Hemostemix Announces Formation of Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm ... quantification of partially hydrolyzed gluten in foods, has been accepted by AOAC International ... “Partially Hydrolyzed Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on ...
(Date:7/30/2015)... Texas (PRWEB) , ... July 30, 2015 , ... The ... and in-depth study on the current state of the global Propanol market with a ... Sinopec, CNPC, BASF, Eastman, Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch ...
(Date:7/30/2015)... ISN improves the efficiency and effectiveness of contractor management systems. ISN,s online contractor management platform, ... 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... Dallas, TX , ISN has additional offices in Calgary , ...
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's Pony™ NS2006L ... continuous operation up to 1500 bar. The sanitary design gauge of the NS2006L ... contamination. , The Pony™ NS2006L homogenizer is an ideal solution for the processing ...
Breaking Biology Technology:RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2
... ST. LOUIS, Aug. 18 Sigma-Aldrich® Corporation (Nasdaq: ... Borg has been named Vice President and Chief Information ... Borg will lead the Company,s global information systems function ... Chief Financial Officer and Chief Administrative Officer. ...
... SHENYANG, China, Aug. 17 /PRNewswire-Asia-FirstCall/ -- ... ... var shortURL ... by longUrl, so we need to grab the first one. for (var r in data.results) { ...
... ProAmatine -- PHILADELPHIA, Pennsylvania, August 17, 2010 ... ... var shortURL = ""; BitlyCB.alertResponse ... need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } ...
Cached Biology Technology:Sigma-Aldrich Announces Appointment of Magnus Borg as Vice President and Chief Information Officer (CIO) 23SBio Inc. Announces Unaudited Second Quarter Results 23SBio Inc. Announces Unaudited Second Quarter Results 33SBio Inc. Announces Unaudited Second Quarter Results 43SBio Inc. Announces Unaudited Second Quarter Results 53SBio Inc. Announces Unaudited Second Quarter Results 63SBio Inc. Announces Unaudited Second Quarter Results 73SBio Inc. Announces Unaudited Second Quarter Results 83SBio Inc. Announces Unaudited Second Quarter Results 93SBio Inc. Announces Unaudited Second Quarter Results 103SBio Inc. Announces Unaudited Second Quarter Results 113SBio Inc. Announces Unaudited Second Quarter Results 123SBio Inc. Announces Unaudited Second Quarter Results 133SBio Inc. Announces Unaudited Second Quarter Results 143SBio Inc. Announces Unaudited Second Quarter Results 153SBio Inc. Announces Unaudited Second Quarter Results 163SBio Inc. Announces Unaudited Second Quarter Results 173SBio Inc. Announces Unaudited Second Quarter Results 183SBio Inc. Announces Unaudited Second Quarter Results 19Shire plc - Statement re ProAmatine 2Shire plc - Statement re ProAmatine 3Shire plc - Statement re ProAmatine 4Shire plc - Statement re ProAmatine 5Shire plc - Statement re ProAmatine 6
(Date:7/9/2015)... , July 9, 2015  Unchained Labs just ... its acquisition of Avid Nano. Avid Nano designs, ... (DLS) systems.    Also today, Unchained ... and easiest to use protein sizing system. The ... a protein,s hydrodynamic size, size distribution, aggregation population ...
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... Pennsylvania School of Veterinary Medicine have discovered a unique evolutionary ... the form of a primitive version of B cells, white ... the evolution of the adaptive immune system in mammals, where ... primitive innate immunity in fish, where they found that B ...
... U.S. Department of Agriculture; and the University of Haifa in ... the protein, zinc and iron content in the grain, potentially ... of children around the world. , Results from the study ... journal Science. , "Wheat is one of the world's ...
... whose first pictures made the cover of Nature in ... it now appears, they may have been. , This ... evidence for reinterpreting the 600 million-year-old fossils from the ... "complicates our understanding of microfossils thought to be the ...
Cached Biology News:'Killer' B cells demonstrate evolutionary link between fish and mammal immune systems 2'Killer' B cells demonstrate evolutionary link between fish and mammal immune systems 3Wheat gene may boost foods' nutrient content 2Oldest animal fossils may have been bacteria 2
Human/Mouse APLP-1 MAb (Clone 354020) ENTREZ GeneID: 333...
Mouse monoclonal [4i97] to HLA Class 1 A25 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 1 Antigen-A25. Swiss Protein ID: P18462...
... choice of Printing Surface (3 glass slides coated with ... 1 silicon wafer coated with 1000 Angstroms of Gold ... and PDMS Stamps (3 PDMS micropatterned stamps with series ... x 10 mm or 200 um x 10 mm ...
Human Dectin-1/CLEC7A Biotinylated Affinity Purified PAb...
Biology Products: